Effect of Gefapixant (AF-219/MK-7264) on Cough Reflex Sensitivity (MK-7264-015)
Clinical trial NCT02397460 · COMPLETED
Trial details
- NCT number
- NCT02397460
- Sponsor
- Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-29
- Primary completion
- 2016-04-22
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.